Peer-influenced content. Sources you trust. No registration required. This is HCN.
Cardiology Advisor
The Wegovy tablet is the first oral GLP-1 receptor agonist indicated for weight loss and cardiovascular risk reduction in eligible adults.
Endocrinology & Diabetes Nursing March 13th 2026
Epoch Health
“If you exercise and take metformin and your blood glucose does not go down, that’s a problem. People taking metformin also didn’t gain fitness. That means their physical function isn’t getting better, and that could have long-term health risk.” – Steven Malin, Lead Author
Endocrinology & Diabetes Nursing January 29th 2026
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS